Susquehanna International Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.88M Sell
44,486
-17,220
-28% -$1.21M ﹤0.01% 5351
2025
Q4
$4.15M Buy
61,706
+54,441
+749% +$3.66M ﹤0.01% 4324
2025
Q3
$533K Sell
7,265
-175,159
-96% -$11.6M ﹤0.01% 8792
2025
Q2
$9.49M Buy
182,424
+20,179
+12% +$1.15M ﹤0.01% 2903
2025
Q1
$10.4M Buy
162,245
+67,626
+71% +$3.93M ﹤0.01% 2489
2024
Q4
$4.52M Sell
94,619
-608
-0.6% -$31.2K ﹤0.01% 3759
2024
Q3
$5.45M Buy
95,227
+56,968
+149% +$3.27M ﹤0.01% 3463
2024
Q2
$2M Sell
38,259
-22,574
-37% -$990K ﹤0.01% 5100
2024
Q1
$2.47M Sell
60,833
-20,182
-25% -$757K ﹤0.01% 4882
2023
Q4
$2.99M Sell
81,015
-28,871
-26% -$1.09M ﹤0.01% 4579
2023
Q3
$4.2M Sell
109,886
-7,524
-6% -$308K ﹤0.01% 3833
2023
Q2
$4.23M Sell
117,410
-45,416
-28% -$1.55M ﹤0.01% 3790
2023
Q1
$6.22M Buy
162,826
+69,368
+74% +$3.25M ﹤0.01% 3127
2022
Q4
$5.32M Sell
93,458
-82,285
-47% -$4.21M ﹤0.01% 3140
2022
Q3
$6.95M Buy
175,743
+79,412
+82% +$3.51M ﹤0.01% 2663
2022
Q2
$4.24M Buy
96,331
+43,841
+84% +$1.9M ﹤0.01% 3453
2022
Q1
$2.09M Sell
52,490
-86,138
-62% -$3.07M ﹤0.01% 5377
2021
Q4
$5.58M Buy
138,628
+60,097
+77% +$2.24M ﹤0.01% 3559
2021
Q3
$3.19M Buy
78,531
+56,087
+250% +$2.34M ﹤0.01% 4820
2021
Q2
$1.02M Sell
22,444
-21,196
-49% -$938K ﹤0.01% 7707
2021
Q1
$1.82M Buy
43,640
+16,174
+59% +$738K ﹤0.01% 6151
2020
Q4
$1.17M Sell
27,466
-12,204
-31% -$439K ﹤0.01% 6343
2020
Q3
$1.04M Sell
39,670
-67,418
-63% -$1.88M ﹤0.01% 6017
2020
Q2
$2.87M Buy
107,088
+42,422
+66% +$957K ﹤0.01% 3870
2020
Q1
$1.16M Sell
64,666
-35,892
-36% -$681K ﹤0.01% 5056
2019
Q4
$1.78M Buy
100,558
+3,170
+3% +$54.9K ﹤0.01% 4519
2019
Q3
$1.51M Sell
97,388
-84,026
-46% -$1.38M ﹤0.01% 4801
2019
Q2
$3.12M Buy
+181,414
New +$2.93M ﹤0.01% 3389
2019
Q1
Sell
-163,527
Closed -$2.65M 9236
2018
Q4
$2.39M Buy
163,527
+66,436
+68% +$1.06M ﹤0.01% 3265
2018
Q3
$1.76M Sell
97,091
-185,652
-66% -$3.25M ﹤0.01% 4206
2018
Q2
$4.77M Buy
282,743
+73,091
+35% +$1.38M ﹤0.01% 2765
2018
Q1
$4.11M Sell
209,652
-84,039
-29% -$1.63M ﹤0.01% 2788
2017
Q4
$5.95M Buy
+293,691
New +$5.4M ﹤0.01% 2346
2017
Q1
Sell
-30,586
Closed -$387K 9326
2016
Q4
$302K Buy
+30,586
New +$335K ﹤0.01% 7958
2016
Q3
Sell
-31,302
Closed -$320K 8653
2016
Q2
$270K Buy
+31,302
New +$309K ﹤0.01% 7123
2016
Q1
Sell
-472,533
Closed -$4.45M 9265
2015
Q4
$8.19M Buy
472,533
+173,897
+58% +$2.77M ﹤0.01% 1957
2015
Q3
$4.01M Buy
298,636
+120,669
+68% +$2.42M ﹤0.01% 3005
2015
Q2
$4.02M Sell
177,967
-96,826
-35% -$1.7M ﹤0.01% 3286
2015
Q1
$3.92M Buy
274,793
+232,505
+550% +$3.35M ﹤0.01% 3101
2014
Q4
$408K Sell
42,288
-40,888
-49% -$363K ﹤0.01% 7609
2014
Q3
$757K Buy
83,176
+20,865
+33% +$199K ﹤0.01% 6466
2014
Q2
$615K Sell
62,311
-258,058
-81% -$2.19M ﹤0.01% 7081
2014
Q1
$4.07M Sell
320,369
-82,399
-20% -$1.22M ﹤0.01% 3182
2013
Q4
$6.04M Buy
402,768
+189,941
+89% +$2.44M ﹤0.01% 2674
2013
Q3
$2.35M Buy
212,827
+124,680
+141% +$1.04M ﹤0.01% 3846
2013
Q2
$701K Buy
+88,147
New +$561K ﹤0.01% 5551

Other funds holding HALO

Susquehanna International Group's HALO Position: Q1 2026 in Review

Susquehanna International Group reduced its Halozyme (HALO) stake by 28% in Q1 2026, selling an estimated $1.21M and leaving 44,486 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #5351.

Susquehanna International Group first reported a position in HALO in Q2 2013 and has held it in 46 quarters since. The position peaked at $10.4M in Q1 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Susquehanna International Group held 44,486 shares of Halozyme worth $2.88M as of Q1 2026.
  • Susquehanna International Group sold 17,220 Halozyme shares in Q1 2026, an estimated $1.21M.
  • Halozyme made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5351 holding.
  • Susquehanna International Group first reported a position in Halozyme in Q2 2013 and has held it in 46 quarters since.
  • Susquehanna International Group's Halozyme position peaked at $10.4M in Q1 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.